Jun Hata Selected Research

protein kinase C eta

7/2014	Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry.
1/2011	[Genome-wide association study for ischemic stroke based on the Hisayama study].
2/2007	A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Hata Research Topics

Disease

29	Stroke (Strokes) 01/2021 - 01/2006
21	Ischemic Stroke 04/2019 - 01/2006
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2009
13	Coronary Disease (Coronary Heart Disease) 01/2021 - 07/2008
12	Dementia (Dementias) 01/2022 - 06/2011
10	Insulin Resistance 01/2022 - 11/2009
10	Hypertension (High Blood Pressure) 09/2021 - 01/2006
9	Type 2 Diabetes Mellitus (MODY) 01/2020 - 12/2009
6	Diabetes Mellitus 01/2022 - 01/2016
6	Chronic Renal Insufficiency 04/2021 - 10/2010
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2011
5	Atherosclerosis 03/2020 - 01/2008
5	Stomach Neoplasms (Stomach Cancer) 05/2018 - 04/2009
5	Vascular Diseases (Vascular Disease) 01/2017 - 01/2008
4	Proteinuria 03/2022 - 09/2004
4	Prediabetic State (Prediabetes) 01/2022 - 01/2019
4	Obesity 01/2022 - 01/2006
4	Inflammation (Inflammations) 01/2021 - 07/2003
4	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2014
4	Atrial Fibrillation 01/2021 - 01/2016
4	Infarction (Infarctions) 04/2019 - 02/2009
4	Glucose Intolerance 01/2018 - 09/2010
4	Albuminuria 11/2017 - 11/2012
4	Infections 08/2017 - 04/2009
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 02/2009
4	Hypercholesterolemia 01/2015 - 09/2004
3	Atrophy 01/2022 - 09/2016
3	Embolic Stroke 01/2020 - 11/2013
3	Neoplasms (Cancer) 01/2018 - 11/2012
3	Brain Infarction 01/2016 - 03/2007
3	Hemorrhagic Stroke 11/2009 - 01/2006
2	Dental Caries (Decay, Dental) 01/2022 - 01/2018
2	Embolism (Embolus) 01/2020 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2018 - 06/2013
2	White Coat Hypertension 11/2017 - 06/2013
2	Masked Hypertension 11/2017 - 06/2013
2	Atrophic Gastritis 12/2016 - 06/2012
2	Carotid Artery Diseases 06/2015 - 06/2013
2	Lacunar Stroke 02/2009 - 02/2007
1	Periodontitis 01/2022
1	Nephrosclerosis 01/2022
1	Tooth Loss 01/2022
1	Heart Failure 04/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Cognitive Dysfunction 01/2020

Drug/Important Bio-Agent (IBA)

16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2009
11	CholesterolIBA 01/2021 - 12/2009
9	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2009
8	AlbuminsIBA 01/2022 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 04/2021 - 04/2013
7	Antihypertensive Agents (Antihypertensives)IBA 09/2021 - 09/2004
7	C-Reactive ProteinIBA 01/2021 - 01/2006
6	HDL CholesterolIBA 03/2022 - 09/2013
6	LDL CholesterolIBA 03/2022 - 02/2009
6	pro-brain natriuretic peptide (1-76)IBA 04/2021 - 12/2011
5	CreatinineIBA 01/2020 - 11/2012
4	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2021 - 01/2019
4	Indicators and Reagents (Reagents)IBA 07/2020 - 09/2016
4	Gliclazide (Diamicron)IBA 01/2017 - 10/2012
4	perindopril drug combination indapamideIBA 01/2017 - 10/2012
3	Uric Acid (Urate)IBA 01/2022 - 07/2016
3	ResistinIBA 03/2020 - 11/2009
3	AnticoagulantsIBA 01/2020 - 05/2014
3	Pepsinogen A (Pepsinogen)IBA 05/2018 - 06/2012
3	Angiopoietin-Like Protein 2IBA 01/2016 - 01/2013
3	protein kinase C etaIBA 07/2014 - 02/2007
2	CalciumIBA 01/2022 - 08/2012
2	PotassiumIBA 01/2022 - 08/2012
2	ORALIT (ORS)IBA 01/2022 - 01/2013
2	MagnesiumIBA 01/2022 - 08/2012
2	Vitamin A (Retinol)FDA LinkGeneric 01/2022 - 04/2012
2	Natriuretic PeptidesIBA 01/2021 - 12/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 07/2020
2	Peptides (Polypeptides)IBA 01/2021 - 03/2020
2	Glycated Serum AlbuminIBA 10/2020 - 07/2020
2	Pharmaceutical PreparationsIBA 01/2018 - 05/2014
2	Eicosapentaenoic AcidIBA 12/2017 - 12/2013
2	Arachidonic Acid (Vitamin F)IBA 12/2017 - 12/2013
2	mahuang-tangIBA 11/2017 - 06/2013
2	1,5-anhydroglucitolIBA 01/2017 - 02/2014
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2008
2	ApolipoproteinsIBA 10/2016 - 06/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 12/2013
2	Warfarin (Coumadin)FDA LinkGeneric 01/2016 - 11/2013
2	Angiotensin Receptor AntagonistsIBA 01/2015 - 02/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2014 - 01/2014
2	AdipokinesIBA 09/2014 - 01/2013
2	CytokinesIBA 01/2013 - 01/2008
2	HDL LipoproteinsIBA 10/2010 - 09/2010
2	Protein Kinase CIBA 11/2008 - 02/2007
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2022
1	Dietary Fiber FDA Link 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2014
4	Glycemic Control 04/2019 - 10/2011
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2016
2	Thrombolytic Therapy 07/2015 - 10/2014